SCHEMBL8892225

SCHEMBL8892225

COc1ccc(CC(CC(O[Si](C)(C)C(C)(C)C)C(Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)NC(C(=O)NC(Cc2ccccc2)C(=O)NC(=O)N2CCOCC2)C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 2/20 0.40
PSEN1 P49768 4/20 0.39
PSEN2 P49810 4/20 0.39
APH1B Q8WW43 4/20 0.39
NCSTN Q92542 4/20 0.39
APH1A Q96BI3 4/20 0.39
PSENEN Q9NZ42 4/20 0.39
CTSD P07339 1/20 0.39
APP P05067 1/20 0.39
PSMB8 P28062 7/20 0.39
PSMB5 P28074 4/20 0.39
PSMB9 P28065 3/20 0.39
PSMB1 P20618 2/20 0.39
PSMB10 P40306 2/20 0.39
PSMB2 P49721 2/20 0.39
BACE1 P56817 3/20 0.39
PSMB11 A5LHX3 1/20 0.39
PSMA7 O14818 1/20 0.39
PSMA1 P25786 1/20 0.39
PSMA2 P25787 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8892890 0.95 REN (0.39) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8896021 0.94 REN (0.42) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8895266 0.94 REN (0.42) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8893525 0.94 REN (0.42) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL7442606 0.93 PSEN1 (0.40) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL7435623 0.93 PSEN1 (0.40) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8895910 0.93 PSEN1 (0.39) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8892662 0.93 REN (0.42) RENPSMB8PSMB5PSMB9PSMB10
SCHEMBL8892829 0.92 PSEN1 (0.39) RENPSEN1PSEN2APH1BNCSTN
SCHEMBL8894701 0.92 PSEN1 (0.39) RENPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663168-A ADMINISTERING INHIBITORS OF HIV ASPARATATE PROTEASES CIBA-GEIGY CORPORATION (US) 1997-09-02 US disclosed
US-5643878-A TREATMENT OF RETROVIRAL DISEASES LIKE AIDS CIBA-GEIGY CORPORATION (US) 1997-07-01 US disclosed
EP-0626178-A1 Use of inhibitors of HIV-protease for the treatment of tumorous diseases CIBA-GEIGY AG (CH) 1994-11-30 EP disclosed
EP-0618222-A2 Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid CIBA-GEIGY AG (CH) 1994-10-05 EP disclosed